Biometrik Completed Successful Bioequivalence Studies for Ministry of Health Projects 2025
Writer: Devita Nurul Anggraeni Editor: Oktaviani Utami Dewi
Jakarta, December, 22 2025 - PT Biometrik Riset Indonesia has completed bioequivalence studies and reported the results for four molecules on behalf of twelve pharmaceutical industries participating in the Ministry of Health’s Facilitation Program for Local Change of Active Pharmaceutical Ingredient (API) sources. The completed molecules include Sitagliptin, Sitagliptin–Metformin, Rivaroxaban, and Imatinib, covering a total of twelve projects: seven Sitagliptin projects, one Sitagliptin–Metformin project, three Rivaroxaban projects, ...